TrialBritish journal of clinical pharmacology2013

A randomized phase I study of methanesulfonyl fluoride, an irreversible cholinesterase inhibitor, for the treatment of Alzheimer's disease.

Donald E Moss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.